These final results, together with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the notion of focusing on ACKR3 as a unique strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated Diseases. Publishing this critique https://jessee356hdn0.wikifrontier.com/user